Net Cash Provided by (Used in) Operating Activities |
-455K |
USD |
+11.3% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
470K |
USD |
+6.61% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
21K |
USD |
|
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
400M |
shares |
0% |
Q4 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
55.8M |
shares |
+22% |
Q4 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
36K |
USD |
|
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
744K |
USD |
+30.8% |
Q4 2024 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
5.59M |
USD |
+28.6% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
5.59M |
USD |
+28.6% |
Q2 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-2.9M |
USD |
+16.8% |
Q4 2024 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
5.23M |
USD |
+26.8% |
Q2 2024 |
FY 2024 |
Additional Paid in Capital |
33.3M |
USD |
+5.93% |
Q4 2024 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
FY 2024 |
Interest Expense |
68.9K |
USD |
+4.23% |
Q4 2024 |
Q2 2025 |